Suppr超能文献

四种人乳头瘤病毒L1衣壳蛋白的晶体结构:了解中和单克隆抗体的特异性

Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies.

作者信息

Bishop Brooke, Dasgupta Jhimli, Klein Michael, Garcea Robert L, Christensen Neil D, Zhao Rui, Chen Xiaojiang S

机构信息

Department of Molecular and Computational Biology, University of Southern California, Los Angeles, California 90089, USA.

出版信息

J Biol Chem. 2007 Oct 26;282(43):31803-11. doi: 10.1074/jbc.M706380200. Epub 2007 Sep 4.

Abstract

Human papillomaviruses (HPVs) are known etiologic agents of cervical cancer. Vaccines that contain virus-like particles (VLPs) made of L1 capsid protein from several high risk HPV types have proven to be effective against HPV infections. Raising high levels of neutralizing antibodies against each HPV type is believed to be the primary mechanism of protection, gained by vaccination. Antibodies elicited by a particular HPV type are highly specific to that particular HPV type and show little or no cross-reactivity between HPV types. With an intention to understand the interplay between the L1 structure of different HPV types and the type specificity of neutralizing antibodies, we have prepared the L1 pentamers of four different HPV types, HPV11, HPV16, HPV18, and HPV35. The pentamers only bind the type-specific neutralizing monoclonal antibodies (NmAbs) that are raised against the VLP of the corresponding HPV type, implying that the surface loop structures of the pentamers from each type are distinctive and functionally active as VLPs in terms of antibody binding. We have determined the crystal structures of all four L1 pentamers, and their comparisons revealed characteristic conformational differences of the surface loops that contain the known epitopes for the NmAbs. On the basis of these distinct surface loop structures, we have provided a molecular explanation for the type specificity of NmAbs against HPV infection.

摘要

人乳头瘤病毒(HPV)是宫颈癌已知的病原体。含有由几种高危型HPV的L1衣壳蛋白制成的病毒样颗粒(VLP)的疫苗已被证明对HPV感染有效。产生针对每种HPV类型的高水平中和抗体被认为是疫苗接种获得保护的主要机制。由特定HPV类型引发的抗体对该特定HPV类型具有高度特异性,并且在不同HPV类型之间几乎没有或没有交叉反应性。为了了解不同HPV类型的L1结构与中和抗体的类型特异性之间的相互作用,我们制备了四种不同HPV类型(HPV11、HPV16、HPV18和HPV35)的L1五聚体。这些五聚体仅与针对相应HPV类型的VLP产生的类型特异性中和单克隆抗体(NmAb)结合,这意味着每种类型的五聚体的表面环结构是独特的,并且在抗体结合方面作为VLP具有功能活性。我们已经确定了所有四种L1五聚体的晶体结构,它们的比较揭示了包含已知NmAb表位的表面环的特征性构象差异。基于这些独特的表面环结构,我们对针对HPV感染的NmAb的类型特异性提供了分子解释。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验